Found 20 matching trials
Co-transplantation of MSC in the Setting of Allo-HSCT
PHASE2Mesenchymal stem cells (MSCs) are known to exhibit immunomodulatory, anti-i...
Location
Union Hospital,Fujian Medical University
Stem Cell Injection in Cancer Survivors
PHASE1The primary purpose of this study is to examine the safety and feasibility ...
Location
Stanford University School of Medicine
Efficacy and Safety of UC-MSCs for the Treatment of Steroid-resistant aGVHD Following Allo-HSCT
PHASE3Randomized, open-label, multicenter study to investigate the efficacy and s...
Location
Peking University Insititute of Hematology, Peking University People's Hospital
Allo-HCT MUD for Non-malignant Red Blood Cell (RBC) Disorders: Sickle Cell, Thal, and DBA: Reduced Intensity Conditioning, Co-tx MSCs
PHASE2The main purpose of this project is to cure patients with high risk Sickle ...
Location
Children's Hospital of Alabama
Biochemical Correction of Severe EB by Allo HSCT and "Off-the-shelf" MSCs
PHASE1This is an open-label, single institution, phase II study in patients with ...
Location
University of Minnesota Masonic Cancer Center and Medical Center
Allogeneic ADSCs and Platelet-Poor Plasma Fibrin Hydrogel to Treat the Patients With Burn Wounds (ADSCs-BWs)
PHASE1The purpose of this study is to evaluate safety and efficacy of tissue engi...
Location
The Kyiv City Clinical Hospital โ2
A Study of REcycled CartiLage Auto/Allo IMplantation to Treat and Repair Focal Hip Cartilage Defects
PHASE1The purpose of this research study it to gather information on the safety a...
Status
Active Not Recruiting
Location
Mayo Clinic Rochester
Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III)
PHASE3The aim of this clinical trial is to investigate the safety and efficacy of...
Status
Active Not Recruiting
Location
Children's Hospital Colorado
MSC for Treatment of cGVHD After Allo-HSCT
PHASE2The purpose of this study is to evaluate the efficacy of mesenchymal stem c...
Location
Department of Hematology,Nanfang Hospital, Southern Medical University
MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs
PHASE2This is a single-institution, phase II study to determine the event-free su...
Location
University of Minnesota Masonic Cancer Center and Medical Center